EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery

Mahmoud A El-Meligy iD, Eman M Abd El-Monaem, Abdelazeem S Eltaweil iD, Mohamed S Mohy-Eldin iD, Zyta M Ziora iD, Abolfazl Heydari iD, Ahmed M Omer iD

Molecules · 2024

DOI: 10.3390/molecules29102393 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Mahmoud A El-Meligy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Polymer Institute of the Slovak Academy of Sciences, Dúbravská Cesta 9, 845 41 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Chitosan, Nanocomposites, Antineoplastic Agents, Silver. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid advancements in nanotechnology in the field of nanomedicine have the potential to significantly enhance therapeutic strategies for cancer treatment. There is considerable promise for enhancing the efficacy of cancer therapy through the manufacture of innovative nanocomposite materials. Metallic nanoparticles have been found to enhance the release of anticancer medications that are loaded onto them, resulting in a sustained release, hence reducing the dosage required for drug administration and preventing their buildup in healthy cells. The combination of nanotechnology with biocompatible materials offers new prospects for the development of advanced therapies that exhibit enhanced selectivity, reduced adverse effects, and improved patient outcomes. Chitosan (CS), a polysaccharide possessing distinct physicochemical properties, exhibits favorable attributes for controlled drug delivery due to its biocompatibility and biodegradability. Chitosan nanocomposites exhibit heightened stability, improved biocompatibility, and prolonged release characteristics for anticancer medicines. The incorporation of gold (Au) nanoparticles into the chitosan nanocomposite results in the manifestation of photothermal characteristics, whereas the inclusion of silver (Ag) nanoparticles boosts the antibacterial capabilities of the synthesized nanocomposite. The objective of this review is to investigate the recent progress in the utilization of Ag and Au nanoparticles, or a combination thereof, within a chitosan matrix or its modified derivatives for the purpose of anticancer drug delivery. The research findings for the potential of a chitosan nanocomposite to deliver various anticancer drugs, such as doxorubicin, 5-Fluroacil, curcumin, paclitaxel, and 6-mercaptopurine, were investigated. Moreover, various modifications carried out on the chitosan matrix phase and the nanocomposite surfaces to enhance targeting selectivity, loading efficiency, and pH sensitivity were highlighted. In addition, challenges and perspectives that could motivate further research related to the applications of chitosan nanocomposites in cancer therapy were summarized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanNanocompositesAntineoplastic AgentsSilverMetal NanoparticlesGoldHumansDrug Delivery SystemsDrug CarriersNeoplasmsAnimals

Stichwörter der Autor:innen

cancer therapychitosancytotoxicitydrug deliverygoldnanocompositesilver

Substanzen

ChitosanAntineoplastic AgentsSilverGoldDrug Carriers

Autor:innen und Institutionen

  • Polymer Institute of the Slovak Academy of Sciences, Dúbravská Cesta 9, 845 41 Bratislava, Slovakia.
  • Genomic Signature Cancer Center, Global Teaching Hospital, University of Tanta, Tanta 31527, Egypt.
  • Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21321, Egypt.
  • Department of Engineering, Faculty of Engineering and Technology, University of Technology and Applied Sciences, Ibra 400, Oman.
  • Polymer Materials Research Department, Advanced Technology and New Materials Research Institute (ATNMRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, P.O. Box 21934, Al…
  • The Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.

ORCID-Profile: Mahmoud A El-Meligy, Abdelazeem S Eltaweil, Mohamed S Mohy-Eldin, Zyta M Ziora, Abolfazl Heydari, Ahmed M Omer

Zitieren

APA

El-Meligy, M. A., Abd El-Monaem, E. M., Eltaweil, A. S., Mohy-Eldin, M. S., Ziora, Z. M., Heydari, A., & Omer, A. M. (2024). Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery. Molecules. https://doi.org/10.3390/molecules29102393

Vancouver

El-Meligy MA, Abd El-Monaem EM, Eltaweil AS, Mohy-Eldin MS, Ziora ZM, Heydari A, et al. Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery. Molecules. 2024. doi:10.3390/molecules29102393

BibTeX
@article{ElMeligy2024,
  author = {El-Meligy, Mahmoud A and Abd El-Monaem, Eman M and Eltaweil, Abdelazeem S and Mohy-Eldin, Mohamed S and Ziora, Zyta M and Heydari, Abolfazl and Omer, Ahmed M},
  title = {Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29102393}
}
Kostenlos starten →